Prevention of Progression in Chronic Liver Disease
An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday
(Sprache: Englisch)
In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more...
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
Fr. 232.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Prevention of Progression in Chronic Liver Disease “
Klappentext zu „Prevention of Progression in Chronic Liver Disease “
In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.
Inhaltsverzeichnis zu „Prevention of Progression in Chronic Liver Disease “
- List of Principal Authors- Preface
- Introduction
1. Mechanisms of fibrogenesis
2. Non-invasive markers of liver injury
3. Complications of cirrhosis: the relevance of hepatocellular carcinoma
4. Controlling necroinflammation of liver with SNMC (Stronger Neo Minophagen C): therapy on interferon non-responders
5. Predictive parameters of non-response to standard hepatitis treatment
6. Concepts for the treatment of non-responders in hepatitis
7. Glycyrrhizin: the molecule and present knowledge of action in various liver diseases
8. Dendritic cells in immune responses against hepatitis C virus
9. SNMC in the prevention of cirrhosis and hepatocellular carcinoma: Japanese experience
10. SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials
- Index
Bibliographische Angaben
- 2004, 2004, 130 Seiten, Masse: 16 x 24,1 cm, Gebunden, Englisch
- Herausgegeben von Hiyashi, N.; Manns, M. P.
- Herausgegeben: M. P. Manns, N. Hiyashi
- Verlag: Springer Netherlands
- ISBN-10: 0792387961
- ISBN-13: 9780792387961
- Erscheinungsdatum: 21.07.2004
Sprache:
Englisch
Kommentar zu "Prevention of Progression in Chronic Liver Disease"
0 Gebrauchte Artikel zu „Prevention of Progression in Chronic Liver Disease“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Prevention of Progression in Chronic Liver Disease".
Kommentar verfassen